Effect of GSK3368715 on GBM patient samples, kept in a novel perfusion device for 8-days

ABSTRACT: Glioblastoma patient samples were microdissected into ~20mg pieces and put onto a novel perfusion device, within an hour of resection. Samples were left for 8 days, at a flow rate of 3ul/min, with a media change at day 4. Treatment was with 1uM GSK3368715. Please refer to Barry et al. Lab-on-chip 2023 for details.

ORGANISM(S): Homo sapiens

PROVIDER: GSE226721 | GEO | 2023/05/09

REPOSITORIES: GEO